A
Akihiko Tokaji
Researcher at Toyo University
Publications - 3
Citations - 76
Akihiko Tokaji is an academic researcher from Toyo University. The author has contributed to research in topics: Epidemiology & Feeling. The author has an hindex of 1, co-authored 1 publications receiving 40 citations.
Papers
More filters
Journal ArticleDOI
Kama muta: Conceptualizing and measuring the experience often labelled being moved across 19 nations and 15 languages.
Janis Zickfeld,Thomas W. Schubert,Beate Seibt,Johanna K. Blomster,Patrícia Arriaga,Nekane Basabe,Agata Blaut,Amparo Caballero,Pilar Carrera,Ilker Dalgar,Yi Ding,Kitty Dumont,Valerie Gaulhofer,Asmir Gračanin,Réka Gyenis,Chuan-Peng Hu,Igor Kardum,Ljiljana B. Lazarević,Leemamol Mathew,Sari Mentser,Ravit Nussinson,Mayuko Onuki,Darío Páez,Anna Pásztor,Kaiping Peng,Boban Petrović,José J. Pizarro,Victoria Schönefeld,Magdalena Śmieja,Akihiko Tokaji,Ad J. J. M. Vingerhoets,Anja Vorster,Jonna K. Vuoskoski,Lei Zhu,Alan Page Fiske +34 more
TL;DR: Although the authors observed some variations across cultures, these 5 facets of kama muta are highly correlated in every sample, supporting the validity of the construct and the measure.
Journal ArticleDOI
Invasive Haemophilus influenzae disease among adults in Japan during 2014–2018
Yushi Hachisu,K. Tamura,Koichi Murakami,Jiro Fujita,Hiroshi Watanabe,Yoshinari Tanabe,Koji Kuronuma,Tetsuya Kubota,Kengo Oshima,Takaya Maruyama,Kei Kasahara,Junichiro Nishi,Shuichi Abe,Masahiko Nakamura,Mayumi Kubota,Shinichiro Hirai,Taisei Ishioka,Chiaki Ikenoue,Munehisa Fukusumi,Tomimasa Sunagawa,Motoi Suzuki,Yukihiro Akeda,Kazunori Oishi,Akihito Yokoyama,Hiroki Takahashi,Hiroaki Takeda,Chikako Tsubata,Masayuki Ishida,Masashi Nakamatsu,Masahiro Satou,Yu Suzuki,Junji Seto,Kazue Yahagi,Satoru Yamazaki,Emiko Kumakura,Yuhki Nagai,Sagako Naraya,Mie Uchida,Junko Tanabe,Miyuki Saeki,Takako Yoshida,Akihiko Tokaji,Hiroaki Shigemura,Fuyuki Okamoto,Nobuyuki Sera,Mutsuyo Gokuden,Jun Kudaka,Junko Isobe,Jun-ichi Kanatani +48 more
TL;DR: The clinical presentations of adult IHD patients varied widely; about three-fourths of patients were age ≥ 65 years and their CFR was high, support preventing strategies for IHD among older adults, including the development of NTHi vaccine.